Teklacep Capital Management is categorized under in Boston, MA .
| Business Name: | Teklacep Capital Management |
| Contact Person: | Daniel Omstead, Chief Executive Officer |
| Address: | 2 Liberty Square Floor 9, Boston, Massachusetts 02109 |
| Phone Number: | (617) 772-8500 |
| Website Address: | hqcm.com |
| Annual Revenue (USD): | $500.000.000 to $999.999.999 |
| Founding Year: | 1986 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | |
| SIC Code: | 6726 |
| NAICS Code: | 5239100 |
| Share This Business: | |
| Related Businesses: |
Putnam Health Care Long/Short Fund Lp - Boston, MA 02109 Synchrony Venture Management - Boston, MA 02109 Putnam Voyager Fund Inc - Boston, MA 02109 Belair Capital Fund LLC - Boston, MA 02109 Apex Boston Group - Boston, MA 02109 Global Private Equity Iii-C Limited Partnership - Boston, MA 02109 Global Private Equity Iv-A Limited Partnership - Boston, MA 02109 Putnam High Income Convertible Bond Fund - Boston, MA 02109 Thunderstorm Capital - Boston, MA 02109 |
The company Teklacep Capital Management provides BOTH services in the form of from its single location in Massachusetts. 1 to 4 employees work for Teklacep Capital Management, and the business now earns $500.000.000 to $999.999.999 per annum.
Teklacep Capital Management was launched in 1986 and is classified under SIC code and category 6726 , and NAICS number and grouping 5239100 . To contact Teklacep Capital Management, please call Daniel Omstead, Chief Executive Officer with the phone number (617) 772-8500 or visit its single location at 2 Liberty Square Floor 9 in Boston, Massachusetts 02109.
The location of the single location can also be found using the coordinates 42.3582,-71.05553. Read more details about this business on the webpage hqcm.com or follow the company’s social media accounts, on Twitter and on Facebook.